
Background: To date, all phenotypes distinctions in patients with primary CNS vasculitis (PCNSV) are based on supervised analyses (e.g. methodology used for diagnosis, caliber of affected vessels), which include important biases.
Objectives: To determine whether hierarchical unsupervised cluster analysis identifies a phenotypic distinction in adult patients with PCNSV.
Methods: An agglomerative hierarchical cluster analysis based on the Ward method was conducted, including 153 patients with complete baseline phenotypic characterization in the COVAC’ registry.
Results: The hierarchical analysis identified two main clusters. In Cluster 1 (n=109 patients, 71%), patients more frequently had a motor deficit (p=0.039), ≥ 1 acute brain infarct (p<0.001), and ≥ 1 intracranial stenosis on CT or MR angiogram (p<0.001) than patients in Cluster 2 (n=44 patients, 29%). Conversely, patients in Cluster 2 more frequently had seizures (p<0.001), cognitive impairment (p=0.002), gadolinium-enhanced parenchymal lesions (p<0.001), leptomeningeal enhancement (p<0.001), ≥ 1 cerebral microbleed (p<0.001), and intracranial hemorrhage(s) (p<0.001). In multivariable logistic regression, gadolinium-enhanced parenchymal lesions were significantly associated with Cluster 2 lesions (OR=35.53 [95% CI: 3.91–322.81], p=0.002). Conversely, ≥ 1 acute brain infarct was significantly associated with Cluster 1 (OR=0.003 [95% CI: 0.01–0.03], p<0.001). A CNS biopsy was positive in 11/40 (28%) patients from Cluster 1 and 35/37 (95%) patients from Cluster 2 (p<0.001). At 12 months, functional independence (modified Rankin scale score ≤ 2) did not differ between the two groups (p=0.17). Relapse and mortality rates did not differ between the clusters (p=0.17 and p=0.23, respectively).
Conclusion: This unsupervised analysis of a large PCNSV cohort identified two different clinical and radiological phenotypes with different diagnostic work-ups, which confirms the relevance of distinguishing PCNSV phenotypes according to the sizes of affected vessels.
REFERENCES: NIL.
Acknowledgements: NIL.
Disclosure of Interests: None declared.
© The Authors 2025. This abstract is an open access article published in Annals of Rheumatic Diseases under the CC BY-NC-ND license (